Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Rioja

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|March 14, 2012
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon responseTerry C Fang, Uwe Schaefer, Ingrid Mecklenbrauker, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Science Advances|July 9, 2025
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitorsFarzaneh Shojaee, Esmaeel Azadian, Min Xian Wong, et al.
Nature Communications|July 27, 2022
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promotersIrene Robles-Rebollo, Sergi Cuartero, Adria Canellas-Socias, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Journal of Crohn'S & Colitis|October 2, 2020
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in ColitisLeonie C S De Vries, Mohammed Ghiboub, Patricia H P van Hamersveld, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Journal of Medicinal Chemistry|November 15, 2023
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical ProbeErin Bradley, Lucia Fusani, Chun-Wa Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2021
IFN-γ Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to PsoriasisRosario Luque-Martin, Davina C Angell, Mathias Kalxdorf, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|March 14, 2012
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon responseTerry C Fang, Uwe Schaefer, Ingrid Mecklenbrauker, et al.
British Journal of Cancer|April 29, 2023
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancerMarcos Quintela, David W James, Jetzabel Garcia, et al.
Science Advances|July 9, 2025
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitorsFarzaneh Shojaee, Esmaeel Azadian, Min Xian Wong, et al.
Nature Communications|July 27, 2022
Cohesin couples transcriptional bursting probabilities of inducible enhancers and promotersIrene Robles-Rebollo, Sergi Cuartero, Adria Canellas-Socias, et al.
Molecular Cancer Therapeutics|March 7, 2026
Distinct H3K27 methylation states drive cellular responses to the histone demethylase inhibitor GSK-J4 in ovarian cancer cellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Molecular Cancer Therapeutics|April 27, 2026
Distinct H3K27 Methylation States Drive Cellular Responses to the Histone Demethylase Inhibitor GSK-J4 in Ovarian Cancer CellsMarcos Quintela, Lydia C Powell, Agne Baseviciene, et al.
Journal of Crohn'S & Colitis|October 2, 2020
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in ColitisLeonie C S De Vries, Mohammed Ghiboub, Patricia H P van Hamersveld, et al.
Clinical Epigenetics|April 14, 2023
Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cellsMarcos Quintela, David W James, Agne Pociute, et al.
Journal of Medicinal Chemistry|November 15, 2023
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical ProbeErin Bradley, Lucia Fusani, Chun-Wa Chung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 2021
IFN-γ Drives Human Monocyte Differentiation into Highly Proinflammatory Macrophages That Resemble a Phenotype Relevant to PsoriasisRosario Luque-Martin, Davina C Angell, Mathias Kalxdorf, et al.
Pageof 5